Home/Filings/8-K/0001193125-25-328706
8-K//Current report

enGene Holdings Inc. 8-K

Accession 0001193125-25-328706

$ENGNCIK 0001980845operating

Filed

Dec 21, 7:00 PM ET

Accepted

Dec 22, 4:04 PM ET

Size

359.8 KB

Accession

0001193125-25-328706

Research Summary

AI-generated summary of this filing

Updated

enGene Holdings Inc. Reports FY2025 Financial Results

What Happened

  • enGene Holdings Inc. announced its financial results for the fiscal year ended October 31, 2025. The company issued a press release dated December 22, 2025, and furnished that press release as Exhibit 99.1 to the Form 8‑K (Item 2.02).
  • The Form 8‑K also includes the usual exhibit information (Item 9.01). The filing states the materials are furnished, not “filed,” under the Exchange Act. The report is signed by CFO Ryan Daws.

Key Details

  • Announcement date: December 22, 2025.
  • Reporting period: fiscal year ended October 31, 2025.
  • Press release furnished as Exhibit 99.1 to the Form 8‑K.
  • Company disclaimer: information furnished in this 8‑K is not subject to Section 18 liability and is not incorporated by reference except where expressly stated.

Why It Matters

  • This filing signals that enGene has released its year‑end earnings and related financial information; investors should read the furnished press release (Exhibit 99.1) for details on revenue, earnings, cash position, and any operating highlights or guidance.
  • Because the release is furnished (not filed), it notifies the market of the results but carries different legal treatment under the securities laws—investors should rely on the actual press release and any subsequent filed reports for formal, legally incorporated disclosures.